The embolotherapy market is expected to grow from US$ 3,341.49 million in 2021 to US$ 5,758.28 million by 2028; it is estimated to grow at a CAGR of 8.1% from 2022 to 2028.
Embolotherapy is an occlusion of arteries by introducing balloons, blood clots, coils, or gel foam using an angiographic catheter. The catheter aids in blocking a blood vessel by implanting a balloon or any foreign body to treat bleeding ulcers, close fistulae or arteriovenous malformations, devascularize organs, blood vessel defects, or control inoperable hemorrhage. Embolotherapy is also used to stop blood flow towards and around a tumor during surgery.
The embolotherapy market is segmented into product, disease indication, procedure end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. This report offers insights and in-depth analysis of the market with an emphasis on parameters such as market trends and market dynamics, and the competitive analysis of the globally leading market players.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Embolotherapy Market: Strategic Insights
Market Size Value in US$ 3,341.49 Million in 2021 Market Size Value by US$ 5,758.28 Million by 2028 Growth rate CAGR of 8.1% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Embolotherapy Market: Strategic Insights
| Market Size Value in | US$ 3,341.49 Million in 2021 |
| Market Size Value by | US$ 5,758.28 Million by 2028 |
| Growth rate | CAGR of 8.1% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Lucrative Regions for Embolotherapy Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Rising Patient Preference for Minimally Invasive Procedures Boosts Embolotherapy Market
The number of minimally invasive surgeries is rising as patients increasingly prefer such surgeries due to their lower postoperative pain, postoperative complications, shorter hospital stays, and fast recovery times. Noninvasive or minimally invasive treatments are being developed as alternatives to surgery for patients with early-stage breast cancer. For instance, Trans Arterial Chemo Embolization, also known as TACE, is a minimally invasive procedure typically used to treat hepatocellular carcinoma. TACE is for patients with asymptomatic and unresectable liver cancer. TACE can be used to diminish the size of the tumor and make the patient eligible for liver transplantation. It is considered an evolution from a formerly applied technique called Trans-catheter Arterial Embolization (TAE).
Prostatic artery embolization (PAE) is also a minimally invasive therapy implemented as an elective outpatient technique for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). The number of patients treated with PAE has grown in recent years. Thus, the increasing preference for minimally invasive procedures is fueling the embolotherapy market growth.
Product Insights
Based on the product, the embolotherapy market is bifurcated into embolic agent and support device. The embolic agent is further sub-segmented into microsphere, liquid embolics agents, embolic coils, embolic plug systems, detachable balloons, and others. The support device is further sub-segmented into microcatheters and guidewires. The embolic agents segment hold the largest market share in 2021. Moreover, the same segment is anticipated to register the highest CAGR during the forecast period. The major driving factors for the growth of the embolic agents segment are the increasing use of embolic agents in various interventional radiology procedures and advancements in embolic agents.
Embolotherapy Market, by Product – 2022 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Disease Indication Insights
Based on disease indication, the embolotherapy market is segmented into cancer, peripheral vascular disease , neurological disease, urological and nephrological disorder, gastrointestinal disorder, and others. The cancer is further sub-segmented into liver cancer, kidney cancer, and others. The cancer segment is likely to hold the largest market share in 2021. Moreover, the same segment is expected to record the fastest CAGR from 2022 to 2028. The major driving factors for the growth of the cancer segment are the rising incidences of cancer worldwide.
Disease Indication Insights
Based on disease indication, the embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization (TARE)/selective internal radiation therapy (SIRT), and transarterial chemoembolization (TACE). The transcatheter arterial embolization (TAE) segment hold the largest market share in 2021. Moreover, the same segment is expected to record the fastest CAGR during 2022–2028. The major driving factors for the growth of the transcatheter arterial embolization (TAE) segment are the rising preference for minimally invasive procedures by the elderly, the growing prevalence of chronic diseases, and the rapid growth in the geriatric population.
End-user Insights
Based on end user, the embolotherapy market is segmented into hospital & clinic, ambulatory surgical center, and other end user. In 2021, the hospital & clinic segment is likely to hold the largest share of the market. Moreover, the same segment is expected to register the highest CAGR from 2022 to 2028. The major driving factors for the growth of the hospital & clinic segment are the growing adoption of minimally invasive surgical procedures (including vascular, urological, and neurological), higher patient footfall in hospitals for the treatment of various diseases such as cancer, an increasing number of embolization procedures performed in these facilities, growing adoption of advance and cutting-edge embolotherapy devices to perform complex procedures with precision in big hospitals, small clinics, and critical care units.
Organic developments such as product launches and approvals are highly adopted strategies by companies in the embolotherapy market. A few of the recent key market developments are listed below:
- In April 2022, Boston Scientific Corporation received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the EMBOLD Fibered Detachable Coil intended to impede or reduce blood flow in the peripheral vasculature. The newest addition to the Boston Scientific interventional oncology portfolio, the EMBOLD Fibered Coil was designed for use in various embolization procedures, a minimally invasive treatment intended to block one or more blood vessels to obstruct or reduce blood flow.
- In September 2021, Abbott announced that it acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots. Walk Vascular's peripheral thrombectomy systems will be incorporated into Abbott's existing endovascular product portfolio.
Company Profiles
- Abbott
- Boston Scientific Corporation
- Cook Medical LLC
- Johnson & Johnson
- Medtronic
- Acandis GmbH
- SSEM Mthembu Medical (Pty) Ltd
- Balt USA LLC
- Stryker
- Guerbet LLC
- Terumo Corporation
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Disease Indication, Procedure, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Embolotherapy is an occlusion of arteries by introducing balloons, blood clots, coils or gel foam using an angiographic catheter. The catheter aids to block a blood vessel by implanting balloon or any foreign body, in order to treat bleeding ulcer, close fistulae or arteriovenous malformations, devascularize organs, blood vessel defect or for control of inoperable hemorrhage. Embolotherapy is also used to stop blood flow towards and around a tumor during surgery.
The factors driving the growth of the embolotherapy market are rising incidence of cancer cases, rising patient preference for minimally invasive procedures, and increasing incidence of hypertension, obesity, smoking, and alcoholism.
The availability of other alternative therapies, and the high cost of embolotherapy are expected to restrict the embolotherapy market growth during the forecast period.
The embolotherapy market majorly consists of the players, such as as Abbott Laboratories, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson Consumer Inc., Medtronic, Acandis GmbH, Terumo Corporation, Balt USA LLC, Stryker Corporation, and Guerbet LLC, among others.
The global embolotherapy market based on product is bifurcated into embolic agents and support devices. The embolic agents is further sub-segmented into microsphere, liquid embolics agents, embolic coils, embolic plug systems, detachable balloons, and others. The support devices is further sub-segmented into microcatheters, and guidewires. The embolic agents segment is likely to hold the largest market share in 2021. Moreover, the same segment is anticipated to register the highest CAGR during the forecast period
The global embolotherapy market based on regions is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In 2021, the North American area held the largest market share. However, the Asia Pacific region is estimated to grow at the fastest CAGR of 8.5% during the forecast period
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Embolotherapy Market – by Product
1.3.2 Global Embolotherapy Market – by Disease Indication
1.3.3 Global Embolotherapy Market – by Procedure
1.3.4 Global Embolotherapy Market – by End User
1.3.5 Global Embolotherapy Market– By Geography
2. Embolotherapy Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Embolotherapy Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East & Africa– PEST Analysis
4.2.5 South & Central America – PEST Analysis
4.3 Expert Opinion
5. Embolotherapy Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Cancer Cases
5.1.2 Rising Patient Preference for Minimally Invasive Procedures
5.1.3 Increasing Incidence of Hypertension, Obesity, Smoking, and Alcoholism
5.2 Market Restraints
5.2.1 Availability of Other Alternative Therapies
5.2.2 High Cost of Embolotherapy
5.3 Market Opportunity
5.3.1 Growing Applications of Embolotherapy
5.4 Market Trend
5.4.1 Increasing Use of Liquid Embolic Agents
5.5 Impact analysis
6. Embolotherapy Market– Global Analysis
6.1 Global Embolotherapy Market Revenue Forecast and Analysis
6.2 Global Embolotherapy Market, By Geography - Forecast and Analysis
6.2.1 Global Embolotherapy Market – Market Potential Analysis, By Region
6.3 Market Positioning of Key Players
6.3.1 Company Analysis
6.3.2 Growth Strategy Analysis
6.3.3 Performance Of Key Players
6.3.3.1 Cook Medical LLC
6.3.3.2 Boston Scientific Corporation
7. Embolotherapy Market Revenue and Forecasts To 2028 by Product
7.1 Overview
7.2 Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)
7.3 Embolic Agents
7.3.1 Overview
7.3.2 Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.3 Microspheres
7.3.3.1 Overview
7.3.3.2 Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.4 Embolic Coils
7.3.4.1 Overview
7.3.4.2 Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.5 Embolic Plug Systems
7.3.5.1 Overview
7.3.5.2 Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.6 Detachable Balloons
7.3.6.1 Overview
7.3.6.2 Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.7 Liquid Embolic Agents
7.3.7.1 Overview
7.3.7.2 Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.8 Others
7.3.8.1 Overview
7.3.8.2 Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Support Devices
7.4.1 Overview
7.4.2 Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.4.3 Microcatheters
7.4.3.1 Overview
7.4.3.2 Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.4.4 Guidewires
7.4.4.1 Overview
7.4.4.2 Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
8. Embolotherapy Market Analysis – By Disease Indication
8.1 Overview
8.2 Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)
8.3 Cancer
8.3.1 Overview
8.3.2 Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Liver Cancer
8.3.2.1.1 Overview
8.3.2.1.2 Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Kidney Cancer
8.3.2.2.1 Overview
8.3.2.2.2 Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Other Cancers
8.3.2.3.1 Overview
8.3.2.3.2 Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Peripheral Vascular Diseases
8.4.1 Overview
8.4.2 Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Neurological Diseases
8.5.1 Overview
8.5.2 Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Urological and Nephrological Disorders
8.6.1 Overview
8.6.2 Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Gastrointestinal Disorders
8.7.1 Overview
8.7.2 Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9. Embolotherapy Market Analysis – By Procedure
9.1 Overview
9.2 Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)
9.3 Transcatheter Arterial Embolization (TAE)
9.3.1 Overview
9.3.2 Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)
9.4.1 Overview
9.4.2 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Transarterial Chemoembolization (TACE)
9.5.1 Overview
9.5.2 Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10. Embolotherapy Market Analysis – By End User
10.1 Overview
10.2 Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Other End Users
10.5.1 Overview
10.5.2 Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11. Embolotherapy Market – Geographic Analysis
11.1 North America: Embolotherapy Market
11.1.1 Overview
11.1.2 North America: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.3 North America Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.1.3.1 North America Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.1.3.2 North America Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.1.4 North America Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.1.4.1 North America Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
11.1.5 North America Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.1.6 North America Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
11.1.7 North America: Embolotherapy Market, by Country, 2022 & 2028 (%)
11.1.7.1 US: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.1 US: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.2 US Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.2.1 US Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.2.2 US Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.3 US Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.3.1 US Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.4 US Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.5 US Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
11.1.7.2 Canada: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.1 Canada: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.2 Canada Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.2.1 Canada Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.2.2 Canada Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.3 Canada Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.3.1 Canada Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.4 Canada Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.5 Canada Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
11.1.7.3 Mexico: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.1 Mexico: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.2 Mexico Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.2.1 Mexico Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.2.2 Mexico Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.3 Mexico Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.3.1 Mexico Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.4 Mexico Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.5 Mexico Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
11.2 Europe: Embolotherapy Market
11.2.1 Overview
11.2.2 Europe: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
11.2.3 Europe Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.2.3.1 Europe Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.2.3.2 Europe Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.2.4 Europe Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.2.4.1 Europe Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
11.2.5 Europe Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.2.6 Europe Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
11.2.7 Europe: Embolotherapy Market, by Country, 2022 & 2028 (%)
11.2.7.1 Germany: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.1 Germany: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.2 Germany Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.2.1 Germany Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.2.2 Germany Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.3 Germany Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.3.1 Germany Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.4 Germany Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.5 Germany Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
11.2.7.2 France: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.1 France: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.2 France Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.2.1 France Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.2.2 France Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.3 France Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.3.1 France Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.4 France Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.5 France Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
11.2.7.3 UK: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.1 UK: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.2 UK, Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.2.1 UK, Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.2.2 UK, Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.3 UK, Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.3.1 UK, Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.4 UK, Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.5 UK, Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
11.2.7.4 Italy: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.1 Italy: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.2 Italy Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.2.1 Italy Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.2.2 Italy Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.3 Italy Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.3.1 Italy Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.4 Italy Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.5 Italy Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
11.2.7.5 Spain: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.1 Spain: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.2 Spain Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.2.1 Spain Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.2.2 Spain Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.3 Spain Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.3.1 Spain Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.4 Spain Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.5 Spain Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
11.2.7.6 Rest of Europe: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.1 Rest of Europe: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.2 Rest of Europe Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.2.1 Rest of Europe Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.2.2 Rest of Europe Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.3 Rest of Europe Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.3.1 Rest of Europe Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.4 Rest of Europe Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.5 Rest of Europe Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
11.3 Asia Pacific: Embolotherapy Market
11.3.1 Overview
11.3.2 Asia Pacific: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
11.3.3 Asia Pacific: Embolotherapy Market, by Product, – Revenue and Forecast to 2028 (US$ Million)
11.3.3.1 Asia Pacific Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.3.3.2 Asia Pacific Embolotherapy Market, by Support Device – Revenue and Forecast to 2028 (US$ Million)
11.3.4 Asia Pacific Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.3.4.1 Asia Pacific Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
11.3.4.2 Asia Pacific Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.3.5 Asia Pacific: Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
11.3.6 Asia Pacific: Embolotherapy Market, by Country, 2022 & 2028 (%)
11.3.6.1 China: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.3.6.1.1 Overview
11.3.6.1.2 China: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.3.6.1.3 China Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.3.6.1.3.1 China Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.3.6.1.3.2 China Embolotherapy Market, by Support Device – Revenue and Forecast to 2028 (US$ Million)
11.3.6.1.4 China Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.3.6.1.4.1 China Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
11.3.6.1.5 China Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.3.6.1.6 China Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
11.3.6.2 Japan: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.3.6.2.1 Japan: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.3.6.2.2 Japan Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.3.6.2.2.1 Japan Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.3.6.2.2.2 Japan Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.3.6.2.3 Japan Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.3.6.2.3.1 Japan Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
11.3.6.2.4 Japan Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.3.6.2.5 Japan Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
11.3.6.3 India: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.3.6.3.1 Overview
11.3.6.3.2 India: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.3.6.3.3 India: Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.3.6.3.3.1 India: Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.3.6.3.3.2 India: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.3.6.3.4 India: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.3.6.3.4.1 India: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
11.3.6.3.5 India: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.3.6.3.6 India: Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
11.3.6.4 South Korea: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.3.6.4.1 Overview
11.3.6.4.2 South Korea: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.3.6.4.3 South Korea: Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.3.6.4.3.1 South Korea: Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.3.6.4.3.2 South Korea: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.3.6.4.4 South Korea: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.3.6.4.4.1 South Korea: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
11.3.6.4.5 South Korea: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.3.6.4.6 South Korea: Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
11.3.6.5 Australia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.3.6.5.1 Overview
11.3.6.5.2 Australia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.3.6.5.3 Australia: Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.3.6.5.3.1 Australia: Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.3.6.5.3.2 Australia: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.3.6.5.4 Australia: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.3.6.5.4.1 Australia: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
11.3.6.5.5 Australia: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.3.6.5.6 Australia: Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
11.3.6.6 Rest of Asia Pacific: Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)
11.3.6.6.1 Overview
11.3.6.6.2 Rest of Asia Pacific: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.3.6.6.3 Rest of Asia Pacific: Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.3.6.6.3.1 Rest of Asia Pacific: Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.3.6.6.3.2 Rest of Asia Pacific: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.3.6.6.4 Rest of Asia Pacific: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.3.6.6.4.1 Rest of Asia Pacific: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
11.3.6.6.5 Rest of Asia Pacific: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.3.6.6.6 Rest of Asia Pacific: Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
11.4 Middle East & Africa: Embolotherapy Market
11.4.1 Overview
11.4.2 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.4.3 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
11.4.3.1 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
11.4.3.2 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
11.4.4 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
11.4.4.1 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
11.4.5 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
11.4.6 Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
11.4.7 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, By Country (%)
11.4.7.1 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.1.1 Overview
11.4.7.1.2 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.1.3 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
11.4.7.1.3.1 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
11.4.7.1.3.2 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
11.4.7.1.4 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
11.4.7.1.4.1 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
11.4.7.1.5 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
11.4.7.1.6 Saudi Arabia: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
11.4.7.2 South Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.2.1 Overview
11.4.7.2.2 South Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.2.3 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
11.4.7.2.3.1 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
11.4.7.2.3.2 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
11.4.7.2.4 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
11.4.7.2.4.1 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
11.4.7.2.5 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
11.4.7.2.6 South Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
11.4.7.3 UAE: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.3.1 Overview
11.4.7.3.2 UAE: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.3.3 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
11.4.7.3.3.1 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
11.4.7.3.3.2 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
11.4.7.3.4 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
11.4.7.3.4.1 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
11.4.7.3.5 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
11.4.7.3.6 UAE: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
11.4.7.4 Rest of Middle East and Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.4.1 Overview
11.4.7.4.2 Rest of Middle East and Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.4.3 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
11.4.7.4.3.1 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
11.4.7.4.3.2 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
11.4.7.4.4 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
11.4.7.4.4.1 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
11.4.7.4.5 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
11.4.7.4.6 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
11.5 South and Central America: Embolotherapy Market
11.5.1 Overview
11.5.2 South and Central America: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
11.5.3 South and Central America Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.5.3.1 South and Central America Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.5.3.2 South and Central America Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.5.4 South and Central America Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.5.4.1 South and Central America Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
11.5.5 South and Central America Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.5.6 South and Central America Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
11.5.7 South and Central America: Embolotherapy Market, by Country, 2022 & 2028 (%)
11.5.7.1 Brazil: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.5.7.1.1 Brazil: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.5.7.1.2 Brazil Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.5.7.1.2.1 Brazil Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.5.7.1.2.2 Brazil Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.5.7.1.3 Brazil Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.5.7.1.3.1 Brazil Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
11.5.7.1.4 Brazil Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.5.7.1.5 Brazil Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
11.5.7.2 Argentina: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.5.7.2.1 Argentina: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.5.7.2.2 Argentina Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.5.7.2.2.1 Argentina Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.5.7.2.2.2 Argentina Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.5.7.2.3 Argentina Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.5.7.2.3.1 Argentina Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
11.5.7.2.4 Argentina Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.5.7.2.5 Argentina Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
11.5.7.3 Rest of South and Central America: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
11.5.7.3.1 Rest of South and Central America: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
11.5.7.3.2 Rest of South and Central America Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.5.7.3.2.1 Rest of South and Central America Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.5.7.3.2.2 Rest of South and Central America Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.5.7.3.3 Rest of South and Central America Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.5.7.3.3.1 Rest of South and Central America Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
11.5.7.3.4 Rest of South and Central America Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.5.7.3.5 Rest of South and Central America Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
12. Impact of COVID-19 Pandemic on Global Embolotherapy Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
12.5 South & Central America: Impact Assessment of COVID-19 Pandemic
13. Embolotherapy Market –Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 Abbott Laboratories
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Boston Scientific Corporation
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Cook Medical LLC
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Johnson & Johnson
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Medtronic
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Acandis GmbH
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Balt USA LLC
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Stryker Corporation
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Guerbet LLC
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Terumo Corporation
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
Table 6. North America Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 7. North America Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 8. US Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 9. US Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 10. US Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 11. US Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 12. US Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
Table 13. US Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 14. US Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 16. Canada Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 17. Canada Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 18. Canada Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 19. Canada Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
Table 20. Canada Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 21. Canada Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 22. Mexico Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 23. Mexico Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 24. Mexico Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 25. Mexico Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 26. Mexico Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
Table 27. Mexico Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 28. Mexico Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 29. Europe Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 30. Europe Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 31. Europe Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 32. Europe Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 33. Europe Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
Table 34. Europe Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 35. Europe Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 36. Germany Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 37. Germany Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 38. Germany Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 39. Germany Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 40. Germany Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
Table 41. Germany Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 42. Germany Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 43. France Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 44. France Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 45. France Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 46. France Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 47. France Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
Table 48. France Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 49. France Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 50. UK, Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 51. UK, Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 52. UK, Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 53. UK, Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 54. UK, Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
Table 55. UK, Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 56. UK, Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 57. Italy Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 58. Italy Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 59. Italy Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 60. Italy Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 61. Italy Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
Table 62. Italy Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 63. Italy Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 64. Spain Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 65. Spain Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 66. Spain Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 67. Spain Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 68. Spain Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
Table 69. Spain Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 70. Spain Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 71. Rest of Europe Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 72. Rest of Europe Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 73. Rest of Europe Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 74. Rest of Europe Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 75. Rest of Europe Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
Table 76. Rest of Europe Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 77. Rest of Europe Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 78. Asia Pacific: Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 79. Asia Pacific Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 80. Asia Pacific Embolotherapy Market, by Support Device – Revenue and Forecast to 2028 (US$ Million)
Table 81. Asia Pacific Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 82. Asia Pacific Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
Table 83. Asia Pacific Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 84. Asia Pacific Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 85. China Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 86. China Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 87. China Embolotherapy Market, by Support Device – Revenue and Forecast to 2028 (US$ Million)
Table 88. China Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 89. China Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
Table 90. China Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 91. China Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 92. Japan Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 93. Japan Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 94. Japan Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 95. Japan Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 96. Japan Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
Table 97. Japan Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 98. Japan Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 99. India: Embolotherapy Market, By Product – Revenue And Forecast To 2028 (US$ Million)
Table 100. India: Embolotherapy Market, By Embolic Agents – Revenue And Forecast To 2028 (US$ Million)
Table 101. India: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 102. India: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 103. India: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
Table 104. India: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 105. India: Embolotherapy Market, By End User– Revenue And Forecast To 2028 (US$ Million)
Table 106. South Korea: Embolotherapy Market, By Product – Revenue And Forecast To 2028 (US$ Million)
Table 107. South Korea: Embolotherapy Market, By Embolic Agents – Revenue And Forecast To 2028 (US$ Million)
Table 108. South Korea: Embolotherapy Market, By Support Devices – Revenue And Forecast To 2028 (US$ Million)
Table 109. South Korea: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 110. South Korea: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
Table 111. South Korea: Embolotherapy Market, By Procedure – Revenue And Forecast To 2028 (US$ Million)
Table 112. South Korea: Embolotherapy Market, By End User– Revenue And Forecast To 2028 (US$ Million)
Table 113. Australia: Embolotherapy Market, By Product – Revenue And Forecast To 2028 (US$ Million)
Table 114. Australia: Embolotherapy Market, By Embolic Agents – Revenue And Forecast To 2028 (US$ Million)
Table 115. Australia: Embolotherapy Market, By Support Devices – Revenue And Forecast To 2028 (US$ Million)
Table 116. Australia: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 117. Australia: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
Table 118. Australia: Embolotherapy Market, By Procedure – Revenue And Forecast To 2028 (US$ Million)
Table 119. Australia: Embolotherapy Market, By End User– Revenue And Forecast To 2028 (US$ Million)
Table 120. Rest of Asia Pacific: Embolotherapy Market, By Product – Revenue And Forecast To 2028 (US$ Million)
Table 121. Rest of Asia Pacific: Embolotherapy Market, By Embolic Agents – Revenue And Forecast To 2028 (US$ Million)
Table 122. Rest of Asia Pacific: Embolotherapy Market, By Support Devices – Revenue And Forecast To 2028 (US$ Million)
Table 123. Rest of Asia Pacific: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 124. Rest of Asia Pacific: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
Table 125. Rest of Asia Pacific: Embolotherapy Market, By Procedure – Revenue And Forecast To 2028 (US$ Million)
Table 126. Rest Of Asia Pacific: Embolotherapy Market, By End User– Revenue And Forecast To 2028 (US$ Million)
Table 127. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million).
Table 128. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
Table 129. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
Table 130. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
Table 131. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
Table 132. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
Table 133. Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 134. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
Table 135. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
Table 136. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
Table 137. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
Table 138. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
Table 139. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
Table 140. Saudi Arabia: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 141. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
Table 142. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
Table 143. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
Table 144. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
Table 145. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
Table 146. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
Table 147. South Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 148. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
Table 149. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
Table 150. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
Table 151. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
Table 152. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
Table 153. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
Table 154. UAE: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 155. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
Table 156. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
Table 157. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
Table 158. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
Table 159. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
Table 160. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
Table 161. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 162. South and Central America Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 163. South and Central America Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 164. South and Central America Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 165. South and Central America Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 166. South and Central America Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
Table 167. South and Central America Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 168. South and Central America Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 169. Brazil Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 170. Brazil Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 171. Brazil Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 172. Brazil Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 173. Brazil Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
Table 174. Brazil Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 175. Brazil Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 176. Argentina Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 177. Argentina Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 178. Argentina Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 179. Argentina Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 180. Argentina Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
Table 181. Argentina Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 182. Argentina Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 183. Rest of South and Central America Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 184. Rest of South and Central America Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 185. Rest of South and Central America Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 186. Rest of South and Central America Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 187. Rest of South and Central America Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)
Table 188. Rest of South and Central America Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 189. Rest of South and Central America Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 190. Organic Developments Done By Companies
Table 191. Inorganic Developments Done by Companies
Table 192. Glossary of Terms, Embolotherapy Market
LIST OF FIGURES
Figure 1. Global Embolotherapy Market Segmentation
Figure 2. Embolotherapy Market, By Region
Figure 3. Embolotherapy Market Overview
Figure 4. Embolic Agents Held Largest Share of Product Segment in Embolotherapy Market
Figure 5. Embolotherapy Market in Asia Pacific Region to Show Remarkable Growth During Forecast Period
Figure 6. Global Embolotherapy Market, By Geography (US$ Million)
Figure 7. Global Embolotherapy Market- Leading Country Markets (US$ Million)
Figure 8. Global Embolotherapy Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Embolotherapy Market Impact Analysis of Drivers and Restraints
Figure 15. Global Embolotherapy Market– Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Embolotherapy Market– By Geography Forecast and Analysis – 2022 & 2028
Figure 17. Global Embolotherapy Market – Market Potential Analysis, By Region
Figure 18. Market Positioning of Key Players in Global Embolotherapy Market
Figure 19. Global Embolotherapy Market – Comparative Company Analysis
Figure 20. Global Embolotherapy Market – Growth Strategy Analysis
Figure 21. Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)
Figure 22. Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 23. Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 24. Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 25. Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 26. Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 27. Liquid Embolics: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 29. Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 30. Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)
Figure 33. Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)
Figure 43. Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)
Figure 47. Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. North America: Embolotherapy Market, by Key Country – Revenue (2022) (US$ Million)
Figure 51. North America Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 52. North America: Embolotherapy Market, by Country, 2022 & 2028 (%)
Figure 53. US: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Canada: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. Mexico: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. Europe: Embolotherapy Market, by Key Country – Revenue (2022) (US$ Million)
Figure 57. Europe Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 58. Europe: Embolotherapy Market, by Country, 2022 & 2028 (%)
Figure 59. Germany: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. France: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 61. UK: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 62. Italy: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 63. Spain: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. Rest of Europe: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 65. Asia Pacific: Embolotherapy Market, by Key Country – Revenue (2022) (US$ Million)
Figure 66. Asia Pacific Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 67. Asia Pacific: Embolotherapy Market, by Country, 2022 & 2028 (%)
Figure 68. China: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 69. Japan: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 70. India: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 71. South Korea: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 72. Australia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 73. Rest Of Asia Pacific: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 74. Middle East & Africa: Embolotherapy Market Revenue Overview, by Country, 2022 (US$ Million)
Figure 75. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 76. Middle East & Africa Embolotherapy Market Revenue and Forecasts to 2028, By Country (%)
Figure 77. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 78. South Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 79. UAE: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 80. Rest of Middle East and Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 81. South and Central America: Embolotherapy Market, by Key Country – Revenue (2022) (US$ Million)
Figure 82. South and Central America Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 83. South and Central America: Embolotherapy Market, by Country, 2022 & 2028 (%)
Figure 84. Brazil: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 85. Argentina: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 86. Rest of South and Central America: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 87. Impact of COVID-19 Pandemic in North American Country Markets
Figure 88. Impact of COVID-19 Pandemic in European Country Markets
Figure 89. Impact of COVID-19 Pandemic in Asia Pacific Countries
Figure 90. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 91. Impact of COVID-19 Pandemic in South & Central America Countries
Figure 92. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Embolotherapy Market
- Abbott Laboratories
- Boston Scientific Corporation
- Cook Medical LLC
- Johnson & Johnson Consumer Inc
- Medtronic
- Acandis GmbH
- Terumo Corporation
- Balt USA LLC
- Stryker Corporation
- Guerbet LLC.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Embolotherapy Market
Aug 2022
Digital PCR (dPCR) Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology [Droplet Digital PCR (ddPCR) and BEAMing Digital PCR], Component (Instruments, Reagents and Consumables, and Software and Services), Application (Clinical, Research, and Forensic), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organization), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Aug 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography